Results 171 to 180 of about 87,295 (197)

Serum phospholipase A in hematological diseases [PDF]

open access: possibleKlinische Wochenschrift, 1989
Inflammatory cells, e.g., neutrophils, monocytes, and macrophages are presumed to be a source of circulating phospholipase A in nonpancreatic diseases. Therefore, we investigated in a preliminary study whether serum phospholipase A activity is related to leukocyte counts in 43 patients with hematological diseases.
R. Th. Hiefinger   +2 more
openaire   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Laparoscopic splenectomy for hematologic diseases

Surgery, 2002
Laparoscopic splenectomy has been demonstrated to be technically feasible and safe for the treatment of hematologic diseases.The study comprised 64 consecutive patients with chronic immune thrombocytopenia purpura (ITP) who were admitted to our hospital from 1992 to 2000 and underwent laparoscopic splenectomy.
Morimasa Tomikawa   +7 more
openaire   +3 more sources

Malignant Hematologic Diseases

2017
Hematologic malignancies affect a significant part of the population including pediatric and young adult population. During the past three decades, the survival and cure rates of these patients have improved due to new therapies. This chapter addresses hematologic malignancies and acute, chronic, lymphoid, and myeloid leukemia as diseases and the ...
Teresa K. Woodruff   +2 more
openaire   +2 more sources

The Hematology and Eye Disease

2019
Blood diseases are diseases that arise spontaneously in the hematopoietic system or affect the hematopoietic system and are accompanied by abnormal blood changes. They include erythrocyte diseases, granulocyte diseases, lymphatic diseases, plasma cell diseases, myeloproliferative diseases, bleeding, thrombotic diseases, etc.
Liqiang Wei, Jingwen Wang, Weihong Yu
openaire   +2 more sources

Hematologic disorders in rheumatic disease

Current Opinion in Rheumatology, 1991
The 1990 literature relating to hematologic disorders in rheumatic disease is reviewed. Two main subject areas of general interest are identified. The anemia of chronic disease has been reviewed and shown to be associated with a variety of medical conditions.
openaire   +3 more sources

Hematologic and Oncologic Diseases and the Liver

Clinics in Liver Disease, 2011
Malignant and nonmalignant disorders may affect the liver, causing signs and symptoms ranging from mild increases of liver tests to fulminant hepatic failure. This article discusses the most common hematologic and oncologic disorders and their effect on the liver.
Marvin M. Singh, Paul J. Pockros
openaire   +3 more sources

Nonmalignant Hematologic Diseases

2017
When we think about hematologic diseases, it is easier to think of malignant conditions. However, there are several nonmalignant hematologic conditions that may have a huge impact on patient’s quality of life. These patients need to receive an appropriate treatment, and starting treatment early is crucial for them to have a good life.
Allison L. Goetsch   +2 more
openaire   +2 more sources

Results of Splenectomy in Hematologic Disease

Archives of Surgery, 1963
Introduction Prediction of success following splenectomy in the treatment of hematologic disease is fraught with uncertainty in all but hereditary spherocytosis in which splenectomy is curative. Careful hematologic evaluation, however, allows us to predict, with considerable accuracy, the results to be expected from splenectomy in several other ...
C. P. Schlicke, S. K. McILVANIE
openaire   +3 more sources

Hematologic Manifestations of Kidney Disease

Seminars in Hematology, 2013
Physiologically, there is an intimate link between the kidney and the blood. Many of the kidney diseases are the result of alteration in the blood such as dysproteinemia, microangiopathic hemolytic anemia (MAHA), hemolysis, etc. On the other hand, the kidney is the organ responsible for the regulation of hematopoiesis.
openaire   +3 more sources

Hematologic Diseases in the Elderly

1987
Although hematopoietic and immunologic parameters undergo a myriad of changes with age, the majority of these changes are clinically insignificant. As this cell population is exquisitely sensitive to changes in general health, surveys attempting to establish “normal” values by screening large numbers of geriatric patients must stringently exclude ...
Steven R. Gambert, Steven R. Gambert
openaire   +2 more sources

Home - About - Disclaimer - Privacy